Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-145.43%
40%
—
9x
60%
—
5 Years
Score4.0
Net Growth-145.43%
Net Trend40%
Net Income Consistency—
Rev Growth9x
Rev Trend60%
Revenue Consistency—
Stoke Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 0.00 to $ 184M and net income went from -$ 50M to -$ 6M. Revenue increased in 3 of those 5 years; net income in 2.
Stoke Therapeutics Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 32.97 | — |
1 Year2025-08-12 | $ 13.53 | 143.68% |
5 Years2021-08-12 | $ 26.11 | 26.27% |
All Time2019-06-19 | $ 25.57 | 28.94% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-06-19 |
|---|---|---|---|---|
| Price | $ 32.97 | $ 13.53 | $ 26.11 | $ 25.57 |
| Return | — | 143.68% | 26.27% | 28.94% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 27M | -$ 207M | $ 292M |
| 2025 | $ 184M | -$ 6M | $ 284M |
| 2024 | $ 36M | -$ 88M | $ 216M |
| 2023 | $ 8M | -$ 104M | $ 201M |
| 2022 | $ 12M | -$ 93M | $ 229M |
| 2021 | $ 3M | -$ 84M | $ 219M |
| 2020 | $ 0.00 | -$ 50M | $ 287M |
| IPO2019 | $ 0.00 | -$ 28M | $ 222M |
Explore beyond STOK
You're looking at Stoke Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
